Top Markets
Coin of the day
Celadon Pharmaceuticals Plc Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals Plc

CEL
Rank in Stocks #40708
Celadon Pharmaceuticals Plc functions as a drug development company,... Celadon Pharmaceuticals Plc functions as a drug development company, concentrating on the discovery, production, and distribution of cannabinoid compounds for certified medical uses. The firm's primary activity involves the indoor, hydroponic cultivation of THC cannabis, which is then incorporated into medicinal products targeting chronic pain. Furthermore, Celadon intends to broaden its research into cannabinoids, exploring their therapeutic applications not only for persistent pain but also for conditions such as autism and multiple sclerosis. Established in 2018, the company maintains its headquarters in London, United Kingdom.
Share Price
$0.00179028
Last synced: 2025-07-28
Market Cap
$94.61K
Change (1 day)
-0.54%
Change (1 year)
0.00%
Country
GB
Trade Celadon Pharmaceuticals Plc (CEL)

Category

Operating Margin for Celadon Pharmaceuticals Plc (CEL)
Operating Margin as of 2026 TTM: 0.00%
According to Celadon Pharmaceuticals Plc latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Celadon Pharmaceuticals Plc from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
23.18% -
IN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.